Asthma Diagnostic Hubs - Fractional exhaled Nitric Oxide (FeNO) Machines, Consumables and Support

Description

This purpose of this notice is to inform the market of a contract awarded to Cicassia Ltd to provide Fractional exhaled Nitric Oxide (FeNO) machines, consumables and support for the use of Primary Care Networks across NHS Hertfordshire and West Essex Integrated Care Board following the successful conclusion of a procurement process. Within Hertfordshire and West Essex currently, the diagnosis of asthma is made mostly in primary care with GP surgeries utilising peak flow diaries and spirometry in most cases. These tools are now deemed to be insufficient and inaccurate, and they do not include the newest, more specific methods of arriving at diagnosis such as FeNO measurements. The data within Hertfordshire and West Essex confirms that there is a significant gap between our expected and estimated asthma prevalence with more than 30% of the population being underdiagnosed. As such, the ICB have procured FeNO machines for use across the ICB Primary Care Networks. As well as the provision of machines, this includes all related consumables. In addition, there will be an online reporting tool / dashboard for the device which is available for clinicians in addition to the provision of training for both clinical and non-clinical staff. Lot 1: This purpose of this notice is to inform the market of a contract awarded to Cicassia Ltd to provide Fractional exhaled Nitric Oxide (FeNO) machines, consumables and support for the use of Primary Care Networks across NHS Hertfordshire and West Essex Integrated Care Board following the successful conclusion of a procurement process. Within Hertfordshire and West Essex currently, the diagnosis of asthma is made mostly in primary care with GP surgeries utilising peak flow diaries and spirometry in most cases. These tools are now deemed to be insufficient and inaccurate, and they do not include the newest, more specific methods of arriving at diagnosis such as FeNO measurements. The data within Hertfordshire and West Essex confirms that there is a significant gap between our expected and estimated asthma prevalence with more than 30% of the population being underdiagnosed. As such, the ICB have procured FeNO machines for use across the ICB Primary Care Networks. As well as the provision of machines, this includes all related consumables. In addition, there will be an online reporting tool / dashboard for the device which is available for clinicians in addition to the provision of training for both clinical and non-clinical staff. Additional information: The contract will start on 1st October 2023 and end on 30th September 2026. Lot 1: This purpose of this notice is to inform the market of a contract awarded to Cicassia Ltd to provide Fractional exhaled Nitric Oxide (FeNO) machines, consumables and support for the use of Primary Care Networks across NHS Hertfordshire and West Essex Integrated Care Board following the successful conclusion of a procurement process. Within Hertfordshire and West Essex currently, the diagnosis of asthma is made mostly in primary care with GP surgeries utilising peak flow diaries and spirometry in most cases. These tools are now deemed to be insufficient and inaccurate, and they do not include the newest, more specific methods of arriving at diagnosis such as FeNO measurements. The data within Hertfordshire and West Essex confirms that there is a significant gap between our expected and estimated asthma prevalence with more than 30% of the population being underdiagnosed. As such, the ICB have procured FeNO machines for use across the ICB Primary Care Networks. As well as the provision of machines, this includes all related consumables. In addition, there will be an online reporting tool / dashboard for the device which is available for clinicians in addition to the provision of training for both clinical and non-clinical staff. Additional information: The contract will start on 1st October 2023 and end on 30th September 2026.